3rd Annual Boston
Breast Cancer Symposium

Living Better and Longer
Through Innovations in Breast Cancer

Friday, April 12, 2019
8:30 am – 1 pm

Starr Center at Massachusetts General Hospital
185 Cambridge Street, 2nd Floor
Boston, MA 02114

The breast cancer landscape is rapidly evolving. Through advances in research and treatment, many breast cancer patients are living better and longer lives. Attend this year’s Breast Cancer Symposium in Boston and hear from leading experts in the field of breast cancer and metastatic breast cancer as they discuss recent breakthroughs that are changing how people are screened, diagnosed, and treated.

There will be a break with coffee and light refreshments served.

Schedule

8:30 am
Registration Opens

8:45 am – 1 pm
Program

Speakers

Regina Barzilay, Ph.D. (Keynote)

Using Artificial Intelligence to Improve Early Breast Cancer Detection

Regina Barzilay is a professor in the Department of Electrical Engineering and Computer Science and a member of the Computer Science and Artificial Intelligence Laboratory at the Massachusetts Institute of Technology. Her research interests are in natural language processing. Currently, Prof. Barzilay is focused on bringing the power of machine learning to oncology. In collaboration with physicians and her students, she is devising deep learning models that utilize imaging, free text, and structured data to identify trends that affect early diagnosis, treatment, and disease prevention. Prof. Barzilay is poised to play a leading role in creating new models that advance the capacity of computers to harness the power of human language data.

Regina Barzilay is a recipient of various awards including an NSF Career Award, the MIT Technology Review TR-35 Award, Microsoft Faculty Fellowship and several Best Paper Awards in top NLP conferences. In 2017, she received a MacArthur fellowship, an ACL fellowship and an AAAI fellowship.

Prof. Barzilay received her MS and BS from Ben-Gurion University of the Negev. Regina Barzilay received her Ph.D. in Computer Science from Columbia University and spent a year as a postdoc at Cornell University.

Laura M. Spring, M.D.

The Neoadjuvant Therapy Model in Breast Cancer

Dr. Spring is a clinical/translational investigator and breast medical oncologist at the Massachusetts General Hospital Cancer Center and Harvard Medical School. She completed her internship and residency in internal medicine at Brigham & Women’s Hospital and her fellowship training in medical oncology at the Dana-Farber Cancer Institute and the Massachusetts General Hospital Cancer Center. The primary focus of Dr. Spring’s research is to develop novel therapeutic and biomarker strategies to improve the care of breast cancer patients.

Dr. Spring is particularly interested in blood-based monitoring of localized breast cancer and the use of targeted therapies and immunotherapy in the neoadjuvant setting. She is involved with the design and conduct of several breast cancer clinical trials for localized and metastatic breast cancer.